1 / 7

UT Task Force Health Science Team

UT Task Force Health Science Team. Akira Takashima, M.D., Ph.D. The University of Toledo College of Medicine. Specific Health Concerns. Microcystin Toxicity. Microbiological Solutions. Expertise & Team Members. Clinical Medicine. Chris Cooper, M.D. (Dean, College of Medicine)

indira-trevino
Télécharger la présentation

UT Task Force Health Science Team

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UT Task Force Health Science Team Akira Takashima, M.D., Ph.D. The University of Toledo College of Medicine Specific Health Concerns Microcystin Toxicity Microbiological Solutions

  2. Expertise & Team Members Clinical Medicine Chris Cooper, M.D. (Dean, College of Medicine) Thomas Sodeman, M.D. (Department of Medicine) Bob Mrak, M.D. (Department of Pathology) Ken Hensley, Ph.D. (Department of Pathology) Public Health & Biosafety Sheryl Milz, Ph.D. (Department of Public Health) Mike Valigosky, Ph.D. (Department of Public Health) April Ames, Ph.D. (Department of Public Health) Microbiology & Molecular Biology Isabel Novella, Ph.D. (Department of Micro & Immunol) Jason Huntley, Ph.D. (Department of Micro & Immunol) George Bullerjahn, Ph.D. (BGSU) Mike McKay, Ph.D. (BGSU)

  3. Specific Resources Clinical Samples & Information blood, urine, biopsy & autopsy samples, clinical tests & information Analytical Chemistry UT-Shimadzu Mass Spec Center Assay Development intravital imaging, flow cytometry, mAb/aptamer production, HTP tests Infrastructures for Translational Research Jacobson Center for Clinical & Translational Research (JCCTR) Center for Biomarker Research & Individualized Medicine (BRIM Center) Department of Laboratory Animal Resources (DLAR) Interprofessional Immersive Simulation Center (IISC)

  4. Measurement of Microcystins in Biological Samples >50 variants Mass Spec ELISA Imaging

  5. Toxicity in Individuals with Preexisting Liver Disease Healthy mice Mice with fatty liver Microcystin in drinking water (small dose) IP injection of microcystin (large dose) 12-72 hours 3-12 months Lethality Acute toxicity Chronic toxicity Comprehensive pathology Pharmacokinetics Motile and cognitive performance

  6. Microbiological Solutions: Use of Natural Enemies Sphingomonas Cyanobacteria Microcystin Degradation Bacteriophage Selective killing

  7. Laboratory Size Treatment of Hospital Water Activated charcoal filter Nanofiltration systems Synthetic filter with Sphingomonas biofilm Recombinant enzymes to degrade microcystin Enzyme pills Microcystin Degradation Sterilization Operation Dialysis

More Related